Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Superior sulcus tumors.

C D Wright1, D J Mathisen

  • 1General Thoracic Surgical Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide Scan of Dental Fear and Anxiety Nominates Novel Genes.

Journal of dental research·2022
Same author

Publisher Correction: Parallel convolutional processing using an integrated photonic tensor core.

Nature·2021
Same author

Parallel convolutional processing using an integrated photonic tensor core.

Nature·2021
Same author

A new forest dwelling button spider from South Africa (Araneae, Theridiidae, Latrodectus).

Zootaxa·2020
Same author

All-optical spiking neurosynaptic networks with self-learning capabilities.

Nature·2019
Same author

New routes to the functionalization patterning and manufacture of graphene-based materials for biomedical applications.

Interface focus·2018
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Superior sulcus tumors, a rare non-small cell lung cancer (NSCLC) type, are often misdiagnosed. New induction chemoradiotherapy shows promise for improving surgical resection rates and survival for these challenging lung cancers.

Area of Science:

  • Thoracic Oncology
  • Surgical Oncology
  • Medical Oncology

Background:

  • Superior sulcus tumors, a form of non-small cell lung cancer (NSCLC), present unique diagnostic and therapeutic challenges.
  • These tumors are frequently misdiagnosed initially, delaying appropriate management.
  • Achieving complete surgical resection is critical for long-term survival but is often hindered by tumor proximity to vital structures.

Purpose of the Study:

  • To review the diagnostic and therapeutic strategies for superior sulcus tumors.
  • To evaluate the efficacy of novel treatment approaches in improving resection rates and patient survival.

Main Methods:

  • Review of current literature on superior sulcus tumor management.
  • Analysis of treatment outcomes, including surgical approaches and neoadjuvant therapies.

Related Experiment Videos

  • Comparison of historical survival data with outcomes from recent studies utilizing induction chemoradiotherapy.

    • Main Results:

    • Standard therapy (induction radiation followed by resection) yields a 5-year survival of approximately 30%.
    • Anterior trans-cervicomediastinal approach facilitates resection of tumors invading anterior structures.
    • Recent studies indicate induction chemoradiotherapy improves complete resection rates and survival compared to historical controls.

    Conclusions:

    • Complete resection is paramount for superior sulcus tumor survival.
    • Induction chemoradiotherapy is emerging as a new standard of care, enhancing resectability and survival for localized NSCLC in the superior sulcus.
    • Multidisciplinary approaches are essential for optimizing treatment outcomes.